NASDAQ:NUVA - Nasdaq - US6707041058 - Common Stock - Currency: USD
The deal spread in Globus Medical's (GMED) planned purchase of Nuvasive (NUVA) widened amid a notice about a closed-door Federal Trade Commission meeting on Wednesday
Mentions: GMED
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
Goosehead Insurance (GSHD) will replace NuVasive (NUVA) in the S&P SmallCap 600, while Jackson Financial (JXN) will replace NexTier Oilfield Solutions (NEX), effective September...
NuVasive (NUVA) rose 3% amid a Nasdaq delisting notice for its planned sale to Globus Medical (GMED)
The deal spread in Globus Medical's (GMED) planned purchase of Nuvasive (NUVA) narrowed amid a report that the companies appear optimistic about regulatory approval for the $3.1...
Mentions: GMED
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
The deal spread in Globus Medicals (GMED) planned takeover of NuVasive (NUVA) widened slightly even as NuVasive stuck with its guidance for the third quarter amid a second request from...
Mentions: GMED
NuVasive press release (NUVA): Q2 Non-GAAP EPS of $0.56 beats by $0.01.Revenue of $317.8M (+2.4% Y/Y) misses by $5.32M.For the second quarter of 2023, GAAP and non-GAAP gross profit...
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
The deal spread in Globus Medical's (GMED) planned takeover of Nuvasive (NUVA) widened slightly amid a report that the Federal Trade Commission is evaluating a path toward a...
Mentions: GMED
NuVasive press release (NUVA): Q1 Non-GAAP EPS of $0.47 beats by $0.05.Revenue of $307.7M (+5.8% Y/Y) beats by $9.26M.The Company continues to expect 2023 net sales growth of 6%ꟷ8%...
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
Mentions: GMED
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
Mentions: GMED
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
Mentions: GMED
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
Canaccord Genuity upgraded Globus Medical (GMED) noting that the selloff, driven by an uncertain outlook to its Nuvasive merger deal is overdone. Read more here.
Mentions: GMED
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...
/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...